Abstract: The present invention relates to the use of lanifibranor or a deuterated form thereof or a pharmaceutical acceptable salt thereof for the treatment of splanchnic vasodilatation in a patient with a liver condition.
| # | Name | Date |
|---|---|---|
| 1 | 202517119719-STATEMENT OF UNDERTAKING (FORM 3) [01-12-2025(online)].pdf | 2025-12-01 |
| 2 | 202517119719-REQUEST FOR EXAMINATION (FORM-18) [01-12-2025(online)].pdf | 2025-12-01 |
| 3 | 202517119719-PROOF OF RIGHT [01-12-2025(online)].pdf | 2025-12-01 |
| 4 | 202517119719-PRIORITY DOCUMENTS [01-12-2025(online)].pdf | 2025-12-01 |
| 5 | 202517119719-POWER OF AUTHORITY [01-12-2025(online)].pdf | 2025-12-01 |
| 6 | 202517119719-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [01-12-2025(online)].pdf | 2025-12-01 |
| 7 | 202517119719-FORM 18 [01-12-2025(online)].pdf | 2025-12-01 |
| 8 | 202517119719-FORM 1 [01-12-2025(online)].pdf | 2025-12-01 |
| 9 | 202517119719-DRAWINGS [01-12-2025(online)].pdf | 2025-12-01 |
| 10 | 202517119719-DECLARATION OF INVENTORSHIP (FORM 5) [01-12-2025(online)].pdf | 2025-12-01 |
| 11 | 202517119719-COMPLETE SPECIFICATION [01-12-2025(online)].pdf | 2025-12-01 |